SummaryThe host response to Borrelia burgdorferi is likely to play a role in the pathogenesis of Lyme arthritis.Whereas most patients with Lyme arthritis can be cured with antibiotic therapy, ~10% of the patients have persistent arthritis for months or even several years after antibiotic treatment. In this study, we tested the hypothesis that the T cell response to one or more antigens of/~ burgdo~ri is different in patients with treatment-responsive or treatment-resistant Lyme arthritis. For this purpose, 313/~ burgdorferi-specific T cell lines were derived from the synovial fluid or peripheral blood of four patients with treatment-responsive Lyme arthritis and five patients with treatmentresistant arthritis. 87 T cell lines from treatment-responsive Lyme arthritis and 112 lines from the treatment-resistant group were examined for the recognition of five recombinant. B. burgdorferi proteins: outer surface proteins A (OspA), B, C, p39, and p93. In both groups of patients, the T cell lines frequently recognized OspB, and only occasionally recognized OspC, p39, and p93. In contrast, OspA was preferentially recognized by T cell lines from patients with treatmentresistant arthritis, but only rarely recognized by T cell lines from patients with treatment-responsive arthritis (odds ratio 28.4, 95% confidence interval 9.2-87.8, p <0.005). These results are compatible with the hypothesis that the T cell response to/~ burgdorferi OspA is involved in the pathogenesis of treatment-resistant Lyme arthritis."[me borreliosis, a tick-borne infection caused by the spirochete Borrelia burgdorferi, is a multisystem disorder.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.